Read about the latest breakthroughs, awards and ongoing work from the SGC. Discover how our work is making a global impact and driving forward the field of drug discovery. Interested in getting first the latest news from SGC?
Oxford, UK, January 12, 2017, Scientists from the Structural Genomics Consortium (SGC) and Oxford University report the first potent and selective chemical probe for the bromodomain of PCAF in an article published in Angewandte Chemie International Edition.
PCAF is a multidomain protein.…
SGC wins Oxford AHSN Public-Private Collaboration Award
Shown left-to-right: John Harris (CEO of OBN), Dr. Rab Prinjha (VP of GSK Medicines Research Centre), Chas Bountra (Director SGC Oxford), Dr. Paul Durrands (COO Oxford AHSN), and Dr. Wen Hwa Lee (Director Disease Foundations…
Target-enabling packages provide a crucial link between human genetics and disease biology to accelerate drug discovery in cancer and malaria
The SGC has released its first set of Target-Enabling Packages (TEPs) to the scientific community.
There is a growing gap between the number…
Categories